'Invisible' stool blood linked to heightened risk of death from all causes

July 16, 2018

'Invisible' blood detected in the stools is linked to a heightened risk of death from all causes, as well as from bowel cancer, reveals research published online in the journal Gut.

In particular, it is associated with a heightened risk of dying from circulatory, respiratory, digestive, blood, hormone and neuropsychological diseases, and other types of cancer, the findings indicate.

A test to pick up the presence of unseen blood in the stools, known as the faecal occult blood test, or FOBT for short, is currently used to screen for bowel cancer or its precursor, polyps, in older people.

Previous research has indicated that stool blood might predict life expectancy, independent of its association with bowel cancer. But potentially influential factors, including drugs that might predispose to internal bleeding--aspirin, for example--were not accounted for.

To try and address this, the researchers drew on linked prescribing, bowel cancer screening, and death registry data for nearly 134,000 people in Tayside, Scotland, from March 2000 to the end of March 2016.

In all, 131,207 people, aged between 50 and 74, tested negative for unseen stool blood and 2714 (just over 2%) tested positive during this period. Their survival was tracked from the date of this first test until death or the end of March 2016, whichever came first.

Older age, increasing levels of deprivation, and male gender were associated with a greater likelihood of a positive test result. Prescriptions for aspirin or other drugs that boost the risk of digestive tract bleeds were also more likely to be associated with a positive test result.

Overall, people who had a positive FOBT result were nearly eight times as likely to die of bowel cancer as those who tested negative, after taking account of gender, age, deprivation, and drug treatment.

But more surprising was that a positive FOBT result was also associated with a 58 percent heightened risk of death from all causes other than bowel cancer.

It was associated with a significantly greater risk of death from circulatory, respiratory, digestive tract, neuropsychological, blood and hormone diseases, as well as other types of cancer, after taking account of potentially influential factors.

The researchers point out that older age, male gender, and increasing levels of deprivation are themselves risk factors for death from all causes. Yet even after adjusting for these factors, a positive FOBT result was still strongly associated with early death.

"Although increased [unseen stool blood] cannot be a cause of death, it may reflect the reason why male gender, age and deprivation are such strong risk factors," they suggest.

This is an observational study, and as such, can't establish cause. And there are no obvious explanations for their findings, point out the researchers.

But they speculate that generalised inflammation, manifest in gut inflammation and bleeding, may provide the missing link, particularly as there is good evidence that most solid cancers and Alzheimer's disease develop against a background of chronic/systemic inflammation.

They go on to suggest that a positive FOBT result might be used to alert bowel cancer screening programme participants who don't have the disease--and around half of those who test positive don't--to the possibility that they might be at risk of other potentially life-limiting illness, and the need for a healthier lifestyle and/or preventive drug treatment.

In a linked commentary, Professor Uri Ladabaum of Stanford University School of Medicine, writes that hidden stool blood "may be telling us more than we might have thought. If the eye is the window to the soul, is a faecal test the window to general health?"

He continues: "Perhaps more importantly, if occult blood in faeces is a predictor of life expectancy and multiple [non-bowel cancer] causes of death, the inevitable next questions concern the implications for organised [bowel cancer] screening programmes or opportunistic [bowel cancer] screening."
-end-


BMJ

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.